Quince Therapeutics, Inc. (QNCX)
Market Open
11 Aug, 15:23
NASDAQ (NGS) NASDAQ (NGS) Primary $
31. 31
+0.66
+2.1533%
$
8.41M Market Cap
- P/E Ratio
- Div Yield
8,310 Volume
0 Eps
$ 30.65
Previous Close Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Drew Phillips Fortitude Family Office LLC | 40 | $36.82 | $935.6 | $898.78 | 2,441.01% |
 David Millar Gen-Wealth Partners Inc | 165 | $151.88 | $5,057.25 | $4,905.37 | 3,229.77% |
